Melanoma Clinical Trials in Colorado

Showing 221-226 of 226 trials

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if this treatment can improve the time to disease progression.

MelanomaMetastatic MelanomaMalignant Melanoma+1 more

Vical133 participantsStarted Feb 2001

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +13 more locations

UNKNOWNPhase 250 miles

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

NCT00383851

This is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma. Patients will be randomized (1:1) between temozolomide and ATN-224 and temozolomide followed by ATN-224. Patients assigned to the sequential treatment group will receive temozolomide until progression of disease is documented and then receive ATN-224 as a single agent until documentation of progression of disease using the last tumor assessment on temozolomide therapy as the baseline assessment.

Melanoma

Attenuon60 participantsStarted Sep 2006

Tucson, Arizona, United States • Encinitas, California, United States • Orange, California, United States +14 more locations

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Melanoma Trials in Other Cities

Vaccine Therapy for Patients With Stage IV Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Study of XL281 in Adults With Solid Tumors

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

Other Conditions in Colorado